BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12834859)

  • 1. Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro.
    Lin JC
    Antiviral Res; 2003 Jun; 59(1):41-7. PubMed ID: 12834859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: structure-activity relationships.
    Lin JC; Cherng JM; Hung MS; Baltina LA; Baltina L; Kondratenko R
    Antiviral Res; 2008 Jul; 79(1):6-11. PubMed ID: 18423902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells.
    Yajima Y; Nonoyama M
    J Virol; 1976 Jul; 19(1):187-94. PubMed ID: 181594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication.
    Lin JC; DeClercq E; Pagano JS
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1431-3. PubMed ID: 2823699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenofovir prodrugs potently inhibit Epstein-Barr virus lytic DNA replication by targeting the viral DNA polymerase.
    Drosu NC; Edelman ER; Housman DE
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12368-12374. PubMed ID: 32409608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus.
    Lin JC; Smith MC; Pagano JS
    J Virol; 1984 Apr; 50(1):50-5. PubMed ID: 6321799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of drugs inhibiting Epstein-Barr virus replication.
    Liu MY; Yen HK; Chern JW; Tsai CH; Yang CS; Chen JY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1996 May; 29(2):80-9. PubMed ID: 10592789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of 1-beta-D-arabinofuranosylthymine on synthesis of Epstein-Barr virus.
    Yonemura K; Sairenji T; Hinuma Y
    Microbiol Immunol; 1981; 25(6):557-63. PubMed ID: 6268944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid.
    Summers WC; Klein G
    J Virol; 1976 Apr; 18(1):151-5. PubMed ID: 176457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function.
    Verma D; Thompson J; Swaminathan S
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3609-14. PubMed ID: 26976570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency.
    Bentz GL; Lowrey AJ; Horne DC; Nguyen V; Satterfield AR; Ross TD; Harrod AE; Uchakina ON; McKallip RJ
    PLoS One; 2019; 14(5):e0217578. PubMed ID: 31125383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time quantitative PCR for assessment of antiviral drug effects against Epstein-Barr virus replication and EBV late mRNA expression.
    Ballout M; Germi R; Fafi-Kremer S; Guimet J; Barguès G; Seigneurin JM; Morand P
    J Virol Methods; 2007 Jul; 143(1):38-44. PubMed ID: 17368820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of adenine arabinoside on Epstein-Barr virus in vitro.
    Coker-Vann M; Dolin R
    J Infect Dis; 1977 Mar; 135(3):447-53. PubMed ID: 191542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on interactions of acyclovir with Epstein-Barr and other herpes viruses.
    Pagano JS; Datta AK
    Am J Med; 1982 Jul; 73(1A):18-26. PubMed ID: 6285710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of inhibition of Epstein-Barr virus replication by phosphonoformic acid.
    Datta AK; Hood RE
    Virology; 1981 Oct; 114(1):52-9. PubMed ID: 6269292
    [No Abstract]   [Full Text] [Related]  

  • 16. Demethylation of the Epstein-barr virus origin of lytic replication and of the immediate early gene BZLF1 is DNA replication independent. Brief report.
    Falk KI; Ernberg I
    Arch Virol; 1999; 144(11):2219-27. PubMed ID: 10603176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of phosphonoacetic acid on the expression of Epstein-Barr viral antigens and virus production.
    Nyormoi O; Thorley-Lawson DA; Elkington J; Strominger JL
    Proc Natl Acad Sci U S A; 1976 May; 73(5):1745-8. PubMed ID: 179098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of adenine arabinoside on lymphocytes infected with Epstein-Barr virus.
    Benz WC; Siegel PJ; Baer J
    J Virol; 1978 Sep; 27(3):475-82. PubMed ID: 212577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of a cellular inhibitor of Epstein-Barr and cytomegalovirus synthesis.
    Glaser R; Zimmerman J; St Jeor S; Rapp F
    Virology; 1975 Mar; 64(1):289-92. PubMed ID: 163544
    [No Abstract]   [Full Text] [Related]  

  • 20. Replication of Epstein-Barr virus DNA in lymphoblastoid cells treated for extended periods with acyclovir.
    Colby BM; Shaw JE; Datta AK; Pagano JS
    Am J Med; 1982 Jul; 73(1A):77-81. PubMed ID: 6285738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.